azacitidine has been researched along with Nevus, Pigmented in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Feige, U; Hamed, E; Hanft, KM; Hettmer, S; Kaiser, M; Krengel, S; Meiss, F; Niemeyer, C; Pietsch, T; Schneider, M; Würtemberger, J | 1 |
Nakagawa, H; Nobeyama, Y | 1 |
Furukawa, H; Hamada, J; Hata, S; Maeda, K; Moriuchi, T; Murai, T; Saito, A; Tada, M; Tsutsumida, A; Yamamoto, Y | 1 |
Guan, X; Koganehira, Y; Oguchi, M; Sagara, J; Saida, T; Taniguchi, S; Yokoyama, T | 1 |
4 other study(ies) available for azacitidine and Nevus, Pigmented
Article | Year |
---|---|
Combinatorial effects of azacitidine and trametinib on NRAS-mutated melanoma.
Topics: Azacitidine; Child, Preschool; GTP Phosphohydrolases; Humans; Male; Melanoma; Membrane Proteins; Meningeal Neoplasms; Mitogen-Activated Protein Kinase Kinases; Mutation; Nevus, Pigmented; Protein Kinase Inhibitors; Pyridones; Pyrimidinones; Skin Neoplasms | 2022 |
Silencing of metallothionein 1A gene in melanoma.
Topics: 5' Untranslated Regions; Adolescent; Adult; Aged; Aged, 80 and over; Azacitidine; Cell Line, Tumor; Child; CpG Islands; Decitabine; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Male; Melanocytes; Melanoma; Metallothionein; Middle Aged; Nevus, Pigmented; Real-Time Polymerase Chain Reaction; Skin Neoplasms; Young Adult | 2017 |
PAX4 has the potential to function as a tumor suppressor in human melanoma.
Topics: Adult; Aged; Aged, 80 and over; Azacitidine; Cell Cycle; Cell Line, Tumor; Cell Proliferation; DNA Methylation; DNA Replication; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Homeodomain Proteins; Humans; Male; Melanoma; Middle Aged; Nevus, Pigmented; Paired Box Transcription Factors; RNA, Messenger; Skin Neoplasms; Time Factors; Transfection; Tumor Suppressor Proteins | 2008 |
ASC/TMS1, a caspase-1 activating adaptor, is downregulated by aberrant methylation in human melanoma.
Topics: Apoptosis; Azacitidine; Blotting, Western; CARD Signaling Adaptor Proteins; Caspase 1; CpG Islands; Cytoskeletal Proteins; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Primers; DNA, Neoplasm; Down-Regulation; Enzyme Activation; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Melanoma; Nevus, Pigmented; Polymerase Chain Reaction; Proteins; Skin Neoplasms; Sulfites; Tumor Cells, Cultured | 2003 |